
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1136 | 1026 | 1136 | 1319 | 1587 | - |
Fund Return | 13.57% | 2.64% | 13.57% | 9.67% | 9.67% | - |
Place in category | 420 | 479 | 420 | 104 | 175 | - |
% in Category | 29 | 31 | 29 | 8 | 19 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FTSE Dev World ex UK Equity Index A | 19.26B | 2.11 | 12.48 | 12.47 | ||
FTSE Dev World ex UK Equity Index I | 19.26B | 2.11 | 12.48 | 12.47 | ||
VG Institutional Plus GBP Income | 17.82B | 21.82 | 10.12 | 12.83 | ||
VG Plus GBP Accumulation | 17.82B | 21.79 | 10.12 | 12.83 | ||
Plus GBP Accumulation | 16.9B | 27.81 | 11.59 | 14.89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guinness Global Equity Income Z | 7.09B | 1.69 | 8.74 | 11.61 | ||
Fidelity Global Dividend Fund A ACC | 3.67B | 10.41 | 11.35 | 10.02 | ||
Fidelity Global Dividend Fund W Acc | 3.67B | 10.88 | 12.20 | 10.84 | ||
Fidelity Global Dividend Fund W Inc | 3.67B | 10.90 | 12.21 | 10.86 | ||
GB00BKPT8X07 | 3.53B | 7.40 | 12.68 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Micro E-mini S&P 500 Index Future Mar 25 | - | 4.03 | - | - | |
Merck&Co | US58933Y1055 | 2.11 | 80.37 | +1.17% | |
J&J | US4781601046 | 2.09 | 171.53 | +0.55% | |
Bank of America | US0605051046 | 1.98 | 44.92 | -1.10% | |
Philip Morris | US7181721090 | 1.86 | 168.17 | +0.71% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review